Search Results

LG 100268 10mg 10mg  | Purity Not Available

Adooq Bioscience

LG 100268 is a potent RXR agonist for evaluation in the treatment of non-insulin-dependent (type II) diabetes mellitus (NIDDM).

More Information Supplier Page

Piperlongumine 50mg 50mg  | Purity Not Available

Adooq Bioscience

Piperlongumine selectively kills cancer cells regardless of p53 status without harming normal cells. It binds to and inihbits proteins known to regulate oxidative stress, in particular, Glutathione S-transferase pi 1 (GSTP1).

More Information Supplier Page

Piperlongumine 25mg 25mg  | Purity Not Available

Adooq Bioscience

Piperlongumine selectively kills cancer cells regardless of p53 status without harming normal cells. It binds to and inihbits proteins known to regulate oxidative stress, in particular, Glutathione S-transferase pi 1 (GSTP1).

More Information Supplier Page

Piperlongumine 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Piperlongumine selectively kills cancer cells regardless of p53 status without harming normal cells. It binds to and inihbits proteins known to regulate oxidative stress, in particular, Glutathione S-transferase pi 1 (GSTP1).

More Information Supplier Page

FPH2 50mg 50mg  | Purity Not Available

Adooq Bioscience

FPH2 (BRD-9424) is a small molecule, which promotes differentiation of iPS-derived hepatocytes.

More Information Supplier Page

LG 100268 5mg 5mg  | Purity Not Available

Adooq Bioscience

LG 100268 is a potent RXR agonist for evaluation in the treatment of non-insulin-dependent (type II) diabetes mellitus (NIDDM).

More Information Supplier Page

TMP 269 10mg 10mg  | Purity Not Available

Adooq Bioscience

TMP 269 is a potent, selective class IIa HDAC inhibitor with IC50 of 157 nM, 97 nM, 43 nM and 23 nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively.

More Information Supplier Page